IP Library Granted Patent US 9,637,556
Granted Patent B2
US 9,637,556 · App. 14/052,451 · Granted May 2, 2017

Methods of generating libraries and uses thereof

Inventors: Peter M. Bowers (San Diego, CA); Andrew B. Cubitt (San Diego, CA); Robert A. Horlick (San Diego, CA)
Assignee: AnaptysBio, Inc.
C07K16/461C07K16/00C07K16/22C07K16/40C07K2317/21C07K2317/565C07K2317/92C40B50/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,637,556
App. No.
14/052,451
Granted
May 2, 2017
Kind
B2
Abstract

This invention relates to methods for the generation of humanized antibodies, particularly a humanized antibody heavy chain protein and a humanized antibody light chain protein. The method comprises using cells that express or can be induced to express Activation Induced Cytidine Deaminase (AID).

Claims (38)

1. A method of preparing a library of antibody heavy chain-encoding polynucleotides, which method comprises:

(a) preparing a first library of nucleic acid sequences, wherein each nucleic acid sequence encodes a different CDR3 domain of an antibody heavy chain variable region,

(b) preparing a second library of nucleic acid sequences, wherein each nucleic acid sequence encodes a template antibody heavy chain variable region domain that lacks an endogenous CDR3 domain,

(c) preparing a third library of nucleic acid sequences, wherein each nucleic acid sequence encodes an antibody heavy chain constant region template,

(d) operably linking the nucleic acid sequences of the libraries of (a), (b), and (c) in an expression vector to produce a fourth library of antibody heavy chain-encoding polynucleotides,

(e) transforming host cells with the library of antibody heavy chain-encoding polynucleotides produced in step (d), and

(f) expressing Activation Induced Cytidine Deaminase (AID) in the host cells,

wherein AID induces one or more mutations in the library of antibody heavy chain-encoding polynucleotides transformed into the host cells in step (e) to provide a fifth library of heavy chain-encoding polynucleotides.

2. The method of claim 1 , wherein the template heavy chain variable region is IGHV6-1, IGHV4-34, IGHV4-59, IGHV3-30-3, IGHV3-7, IGHV3-23, IGHV5-51, IGHV1-2, or IGHV1-69.

3. A method of preparing a library of antibody light chain-encoding polynucleotides, which method comprises:

(a) preparing a first library of nucleic acid sequences, wherein each nucleic acid sequence encodes a different CDR3 domain of an antibody light chain variable region,

(b) preparing a second library of nucleic acid sequences, wherein each nucleic acid sequence encodes a template antibody light chain variable region domain that lacks an endogenous CDR3 domain,

(c) preparing a third library of nucleic acid sequences, wherein each nucleic acid sequence encodes an antibody light chain constant region template,

(d) operably linking the nucleic acid sequences of the libraries of (a), (b), and (c) in an expression vector to produce a fourth library of antibody light chain-encoding polynucleotides,

(e) transforming host cells with the library of antibody light chain-encoding polynucleotides produced in step (d), and

(f) expressing Activation Induced Cytidine Deaminase (AID) in the host cells,

wherein AID induces one or more mutations in the library of antibody heavy chain-encoding polynucleotides transformed into the host cells in step (e) to provide a fifth library of heavy chain-encoding polynucleotides.

4. The method of claim 3 , wherein the template light chain variable region is IGKLV7-43, IGLV1-40, IGLV2-11, or IGLV3-21.

5. A method of preparing a library of heavy chain-encoding polynucleotides and light chain-encoding polynucleotides, wherein the method comprises

(i) preparing a library of heavy chain-encoding polynucleotides by:

(i-a) preparing a first library of nucleic acid sequences, wherein each nucleic acid sequence encodes a different CDR3 domain of an antibody heavy chain variable region,

(i-b) preparing a second library of nucleic acid sequences, wherein each nucleic acid sequence encodes a template antibody heavy chain variable region domain that lacks an endogenous CDR3 domain,

(i-c) preparing a third library of nucleic acid sequences, wherein each nucleic acid sequence encodes an antibody heavy chain constant region template, and

(i-d) operably linking the nucleic acid sequences of the libraries of (i-a), (i-b), and (i-c) in an expression vector to produce a fourth library of antibody heavy chain-encoding polynucleotides;

and

(ii) preparing a library of antibody light chain-encoding polynucleotides by:

(ii-a) preparing a first library of nucleic acid sequences, wherein each nucleic acid sequence encodes a different CDR3 domain of an antibody light chain variable region,

(ii-b) preparing a second library of nucleic acid sequences, wherein each nucleic acid sequence encodes a template antibody light chain variable region domain, wherein the template light chain variable region domain that lacks an endogenous CDR3 domain,

(ii-c) preparing a third library of nucleic acid sequences, wherein each nucleic acid sequence encodes an antibody light chain constant region template, and

(ii-d) operably linking the nucleic acid sequences of the libraries of (ii-a), (ii-b), and (ii-c) in an expression vector to produce a fourth library of antibody light chain-encoding polynucleotides,

(iii) transforming host cells with the library of antibody heavy chain-encoding polynucleotides produced in step

(i-d) and the library of antibody light chain-encoding polynucleotides produced in step (ii-d), and

(iv) expressing Activation Induced Cytidine Deaminase (AID) in the host cells,

wherein AID induces one or more mutations in the library of antibody heavy chain-encoding polynucleotides and antibody light chain-encoding polynucleotides to produce a new library of antibody heavy chain-encoding polynucleotides and antibody light chain-encoding polynucleotides.

6. The method of claim 5 , wherein the template heavy chain variable region is IGHV6-1, IGHV4-34, IGHV4-59, IGHV3-30-3, IGHV3-7, IGHV3-23, IGHV5-51, IGHV1-2, or IGHV1-69; and the template light chain variable region is IGKLV7-43, IGLV1-40, IGLV2-11, or IGLV3-21.

7. A method of preparing a human antibody, which method comprises:

preparing a library of antibody heavy chain-encoding polynucleotides and light chain-encoding polynucleotides by the method of claim 5 , whereupon antibodies are produced in the host cells; and

identifying one or more human antibodies from the host cells having a desired property.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2013
From: BOWERS, PETER M.; CUBITT, ANDREW B.; HORLICK, ROBERT A.
To: ANAPTYSBIO, INC.
Reel/Frame 031392/0162 →
Continuity (6)
Division 12070904 · Feb 20, 2008
Provisional Application 60902414 · Feb 20, 2007
Provisional Application 60904622 · Mar 1, 2007
Provisional Application 60995970 · Sep 28, 2007
Provisional Application 61020124 · Jan 9, 2008
Related Publication 20140094392A1 · Apr 3, 2014